PennyStocksUpdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
New York, NY -- (SBWIRE) -- 01/23/2013 -- Star Scientific, Inc. (NASDAQ:STSI) shares increased 5.60% and closed at $2.64. The company, on Jan. 7, announced the preliminary results of the Company’s ASAP (Anatabloc Supplementation Autoimmune Prevention) Human Thyroid Study that analyzes the impact of anatabine dietary supplementation on thyroid health. The study is a three-month, five-visit, double-blind, placebo-controlled study of the impact of anatabine dietary supplementation in humans with autoimmune disease of the thyroid.
Can STSI Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Tata Motors Limited (ADR) (NYSE:TTM) decreased 2.57% and closed at $29.95 on a traded volume of 1.51 million shares. Tata Motors Ltd’s Jaguar Land Rover PLC has started assembling two variants of its Jaguar XF sedan in India, a step that will allow the Company to sell the model at cheaper prices to local customers. Jaguar Land Rover has started assembling the sedan with a 3.0-liter diesel engine at its facility in western India’s Pune city.
Is TTM Ready To Move Back To New Highs This Year? Find Out Here
Shares of Ellie Mae (NYSE:ELLI) opened at 26.26 on Wednesday. Ellie Mae has a one year low of $5.56 and a one year high of $30.59. The stock’s 50-day moving average is currently $26.15. The company has a market cap of $673.8 million and a P/E ratio of 36.22.
Ellie Mae last released its earnings data on Wednesday, October 31st. The company reported $0.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.15. The company’s revenue for the quarter was up 87.1% on a year-over-year basis. Ellie Mae has set its Q4 guidance at $0.18-0.19 EPS. Analysts expect that Ellie Mae will post $1.03 EPS for the current fiscal year.
You will receive a concise summary of stock analysts' upgrades, downgrades and news coverage. Click here to subscribe.
Quest Diagnostics Inc. (NYSE:DGX) reported fourth quarter adjusted income from continuing operations of $1.01 per share Wednesday morning, down from $1.20 per share last year. The consensus estimate was for EPS of $1.02. Full year 2013 EPS is expected to between $4.35 and $4.55, compared to the consensus estimate of $4.81.
Quest Diagnostics has gapped open sharply lower Wednesday and is now down 3.93 at $57.90 on above average volume. The stock has dropped to a 2-week low and has fallen below both its 50 and 200-day moving averages.
Click here to receive FREE breaking news email alerts for Quest Diagnostics
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)